查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1874397

藥品追蹤與管理解決方案：全球市佔率與排名、總收入及需求預測（2025-2031年）

Pharma Track and Trace Solutions - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 118 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球藥品追蹤和管理解決方案市場預計在 2024 年達到 22.23 億美元，預計到 2031 年將達到 60.13 億美元，在預測期（2025-2031 年）內以 15.5% 的複合年成長率成長。

可追溯性解決方案不僅僅是提高供應鏈效率的經濟方案。專家估計，全球銷售的藥品有5%是仿冒品，在某些國家，這一比例甚至高達50%。每年有數十億件產品「在供應鏈中丟失」。假藥和非法分銷不僅危及生命，還會造成收入損失，並損害企業聲譽。製藥業必須確保其供應鏈安全，並具備驗證產品電子譜系（ePedigree）或生命週期的能力。可追溯性解決方案是這項策略的重要組成部分。它們可以識別藥品的來源並檢驗其真偽。此外，可追溯性解決方案還有助於打擊產品轉移，即合法產品在不同市場之間未經授權的流動，這會影響授權義務、分銷協議和收入。

藥品追蹤解決方案市場的主要推動力是人們對全球藥品供應鏈安全和病患安全日益成長的擔憂。市場上假藥的氾濫促使世界各地的監管機構實施嚴格的序列化和可追溯性要求，例如美國的「藥品供應鏈安全法案」(DSCSA)、歐盟的「假藥指令」(FMD) 以及其他地區的類似法規。這些監管要求迫使製藥公司採用先進的追蹤溯源技術，以符合法律標準並避免處罰。此外，全球藥品供應鏈日益複雜，涉及多個地域的相關人員，因此，能夠提供端到端可視性和透明度的強大解決方案至關重要。區塊鏈、無線射頻識別 (RFID) 和物聯網 (IoT) 等創新技術的應用將透過增強即時監控能力和確保資料完整性，進一步推動市場成長。此外，消費者和醫療保健提供者對藥品真實性和安全性的日益關注，也催生了對可靠追蹤系統的需求。製藥企業和技術供應商在開發經濟高效、擴充性且可互通的追蹤溯源解決方案方面的投資，也大大促進了市場擴張。

儘管藥品追蹤解決方案市場前景廣闊，但仍面臨許多挑戰，可能阻礙其發展。其中一個主要障礙是先進追蹤技術的高昂實施成本。對於中小型製藥公司，尤其是新興市場的企業而言，基礎設施升級、員工培訓以及與現有企業系統的整合都需要大量資金和時間，這可能會延緩技術的採用。此外，缺乏標準化的全球法規以及各國合規要求的差異，造成了市場的複雜性和碎片化，使得製造商難以在全球範圍內實施統一的解決方案。不同追蹤系統之間的互通性問題以及資料隱私問題也構成重大障礙。此外，造假者和供應鏈犯罪分子不斷演變的策略，也要求追蹤解決方案持續創新和更新，加劇了營運挑戰。傳統供應鏈網路內部對變革的抵制以及不同相關人員之間協作的需求，進一步增加了實施難度。應對這些挑戰對於充分發揮藥品追蹤系統在保障藥品供應鏈安全和病人安全的潛力至關重要。

本報告旨在依地區/國家、類型和應用對全球藥品追蹤解決方案市場進行全面分析，重點關注總收入、市場佔有率和主要企業的排名。

本報告以銷售收入為指標，對藥品追蹤溯源解決方案的市場規模、估算和預測進行了呈現，以2024年為基準年，並涵蓋了2020年至2031年的歷史數據和預測數據。報告採用定量和定性分析相結合的方法，幫助讀者制定業務和成長策略，評估市場競爭，分析自身在當前市場中的地位，並就藥品追蹤溯源解決方案做出明智的商業決策。

市場區隔

公司

  • Optel Vision
  • Siemens
  • IBM
  • Axway
  • Mettler-Toledo
  • Systech
  • SAP
  • Seidenader Maschinenbau
  • Antares Vision
  • Sea Vision
  • TraceLink
  • Adents International
  • Xyntek
  • Holoflex
  • ACG Worldwide

依類型分類的區隔市場

  • 條碼
  • RFID

應用領域

  • 生物製藥
  • 化學和製藥
  • 專科藥物

依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Pharma Track and Trace Solutions was estimated to be worth US$ 2223 million in 2024 and is forecast to a readjusted size of US$ 6013 million by 2031 with a CAGR of 15.5% during the forecast period 2025-2031.

Track and trace solutions are not just economic measures for supply-chain efficiency. Experts estimate that 5% of all drugs sold worldwide are counterfeits - in some countries, figures even reach a shocking 50 %. Billions of products are "lost in the supply chain" every year. Counterfeit drugs and product diversion risk lives, undermine revenues, and threaten company reputations. The pharmaceutical industry needs to ensure supply-chain security and gain the ability to authenticate the ePedigree, or life history, of a product. Track and trace solutions are an essential part of this strategy. Track and trace solutions identify the origins of a pharmaceutical industry product and verify its authenticity. Moreover, track and trace solutions also help combat product diversion, whereby legitimate products are diverted from one market to another, with implications for licensing obligations and distribution agreements as well as for revenues.

The Pharma Track and Trace Solutions market is primarily driven by the growing global emphasis on pharmaceutical supply chain security and patient safety. Increasing incidences of counterfeit drugs flooding the market have pushed regulatory authorities worldwide to implement stringent serialization and traceability mandates, such as the U.S. Drug Supply Chain Security Act (DSCSA), the European Union Falsified Medicines Directive (FMD), and similar regulations in other regions. These regulatory requirements compel pharmaceutical companies to adopt advanced track and trace technologies to comply with legal standards and avoid penalties. Additionally, the rising complexity of global pharmaceutical supply chains, involving multiple stakeholders across geographies, necessitates robust solutions that provide end-to-end visibility and transparency. The adoption of innovative technologies like blockchain, RFID, and Internet of Things (IoT) further accelerates market growth by enhancing real-time monitoring capabilities and ensuring data integrity. Moreover, the increasing awareness among consumers and healthcare providers about drug authenticity and safety is creating demand for reliable tracking systems. Investments by pharmaceutical manufacturers and technology providers in developing cost-effective, scalable, and interoperable track and trace solutions also contribute significantly to market expansion.

Despite the promising growth prospects, the Pharma Track and Trace Solutions market faces several challenges that could impede its progress. One of the main hurdles is the high implementation cost associated with advanced track and trace technologies, especially for small and mid-sized pharmaceutical companies operating in emerging markets. The need for infrastructure upgrades, staff training, and integration with existing enterprise systems requires substantial capital and time investments, which may delay adoption. Furthermore, the lack of standardized global regulations and varying compliance requirements across countries create complexity and fragmentation, making it difficult for manufacturers to implement uniform solutions worldwide. Interoperability issues between different track and trace systems and data privacy concerns also pose significant barriers. Additionally, the constantly evolving tactics of counterfeiters and supply chain criminals require continuous innovation and updates to tracking solutions, increasing operational challenges. Resistance to change within traditional supply chain networks and the requirement for collaboration among diverse stakeholders further complicate deployment efforts. Addressing these challenges is critical for realizing the full potential of pharma track and trace systems in safeguarding the pharmaceutical supply chain and ensuring patient safety.

This report aims to provide a comprehensive presentation of the global market for Pharma Track and Trace Solutions, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pharma Track and Trace Solutions by region & country, by Type, and by Application.

The Pharma Track and Trace Solutions market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma Track and Trace Solutions.

Market Segmentation

By Company

  • Optel Vision
  • Siemens
  • IBM
  • Axway
  • Mettler-Toledo
  • Systech
  • SAP
  • Seidenader Maschinenbau
  • Antares Vision
  • Sea Vision
  • TraceLink
  • Adents International
  • Xyntek
  • Holoflex
  • ACG Worldwide

Segment by Type

  • Barcodes
  • RFID

Segment by Application

  • Bio Pharma
  • Chemical Pharma
  • Specially Pharma

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Pharma Track and Trace Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Pharma Track and Trace Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Pharma Track and Trace Solutions in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Pharma Track and Trace Solutions Product Introduction
  • 1.2 Global Pharma Track and Trace Solutions Market Size Forecast (2020-2031)
  • 1.3 Pharma Track and Trace Solutions Market Trends & Drivers
    • 1.3.1 Pharma Track and Trace Solutions Industry Trends
    • 1.3.2 Pharma Track and Trace Solutions Market Drivers & Opportunity
    • 1.3.3 Pharma Track and Trace Solutions Market Challenges
    • 1.3.4 Pharma Track and Trace Solutions Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Pharma Track and Trace Solutions Players Revenue Ranking (2024)
  • 2.2 Global Pharma Track and Trace Solutions Revenue by Company (2020-2025)
  • 2.3 Key Companies Pharma Track and Trace Solutions Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Pharma Track and Trace Solutions Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Pharma Track and Trace Solutions
  • 2.6 Pharma Track and Trace Solutions Market Competitive Analysis
    • 2.6.1 Pharma Track and Trace Solutions Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Pharma Track and Trace Solutions Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma Track and Trace Solutions as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Barcodes
    • 3.1.2 RFID
  • 3.2 Global Pharma Track and Trace Solutions Sales Value by Type
    • 3.2.1 Global Pharma Track and Trace Solutions Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Pharma Track and Trace Solutions Sales Value, by Type (2020-2031)
    • 3.2.3 Global Pharma Track and Trace Solutions Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Bio Pharma
    • 4.1.2 Chemical Pharma
    • 4.1.3 Specially Pharma
  • 4.2 Global Pharma Track and Trace Solutions Sales Value by Application
    • 4.2.1 Global Pharma Track and Trace Solutions Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Pharma Track and Trace Solutions Sales Value, by Application (2020-2031)
    • 4.2.3 Global Pharma Track and Trace Solutions Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Pharma Track and Trace Solutions Sales Value by Region
    • 5.1.1 Global Pharma Track and Trace Solutions Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Pharma Track and Trace Solutions Sales Value by Region (2020-2025)
    • 5.1.3 Global Pharma Track and Trace Solutions Sales Value by Region (2026-2031)
    • 5.1.4 Global Pharma Track and Trace Solutions Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 5.2.2 North America Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 5.3.2 Europe Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Pharma Track and Trace Solutions Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 5.5.2 South America Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Pharma Track and Trace Solutions Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Pharma Track and Trace Solutions Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 6.3.2 United States Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 6.4.2 Europe Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 6.5.2 China Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 6.6.2 Japan Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 6.7.2 South Korea Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 6.9.2 India Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Optel Vision
    • 7.1.1 Optel Vision Profile
    • 7.1.2 Optel Vision Main Business
    • 7.1.3 Optel Vision Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.1.4 Optel Vision Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Optel Vision Recent Developments
  • 7.2 Siemens
    • 7.2.1 Siemens Profile
    • 7.2.2 Siemens Main Business
    • 7.2.3 Siemens Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.2.4 Siemens Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Siemens Recent Developments
  • 7.3 IBM
    • 7.3.1 IBM Profile
    • 7.3.2 IBM Main Business
    • 7.3.3 IBM Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.3.4 IBM Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.3.5 IBM Recent Developments
  • 7.4 Axway
    • 7.4.1 Axway Profile
    • 7.4.2 Axway Main Business
    • 7.4.3 Axway Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.4.4 Axway Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Axway Recent Developments
  • 7.5 Mettler-Toledo
    • 7.5.1 Mettler-Toledo Profile
    • 7.5.2 Mettler-Toledo Main Business
    • 7.5.3 Mettler-Toledo Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.5.4 Mettler-Toledo Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Mettler-Toledo Recent Developments
  • 7.6 Systech
    • 7.6.1 Systech Profile
    • 7.6.2 Systech Main Business
    • 7.6.3 Systech Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.6.4 Systech Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Systech Recent Developments
  • 7.7 SAP
    • 7.7.1 SAP Profile
    • 7.7.2 SAP Main Business
    • 7.7.3 SAP Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.7.4 SAP Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.7.5 SAP Recent Developments
  • 7.8 Seidenader Maschinenbau
    • 7.8.1 Seidenader Maschinenbau Profile
    • 7.8.2 Seidenader Maschinenbau Main Business
    • 7.8.3 Seidenader Maschinenbau Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.8.4 Seidenader Maschinenbau Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Seidenader Maschinenbau Recent Developments
  • 7.9 Antares Vision
    • 7.9.1 Antares Vision Profile
    • 7.9.2 Antares Vision Main Business
    • 7.9.3 Antares Vision Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.9.4 Antares Vision Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Antares Vision Recent Developments
  • 7.10 Sea Vision
    • 7.10.1 Sea Vision Profile
    • 7.10.2 Sea Vision Main Business
    • 7.10.3 Sea Vision Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.10.4 Sea Vision Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Sea Vision Recent Developments
  • 7.11 TraceLink
    • 7.11.1 TraceLink Profile
    • 7.11.2 TraceLink Main Business
    • 7.11.3 TraceLink Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.11.4 TraceLink Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.11.5 TraceLink Recent Developments
  • 7.12 Adents International
    • 7.12.1 Adents International Profile
    • 7.12.2 Adents International Main Business
    • 7.12.3 Adents International Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.12.4 Adents International Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Adents International Recent Developments
  • 7.13 Xyntek
    • 7.13.1 Xyntek Profile
    • 7.13.2 Xyntek Main Business
    • 7.13.3 Xyntek Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.13.4 Xyntek Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.13.5 Xyntek Recent Developments
  • 7.14 Holoflex
    • 7.14.1 Holoflex Profile
    • 7.14.2 Holoflex Main Business
    • 7.14.3 Holoflex Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.14.4 Holoflex Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.14.5 Holoflex Recent Developments
  • 7.15 ACG Worldwide
    • 7.15.1 ACG Worldwide Profile
    • 7.15.2 ACG Worldwide Main Business
    • 7.15.3 ACG Worldwide Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.15.4 ACG Worldwide Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.15.5 ACG Worldwide Recent Developments

8 Industry Chain Analysis

  • 8.1 Pharma Track and Trace Solutions Industrial Chain
  • 8.2 Pharma Track and Trace Solutions Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Pharma Track and Trace Solutions Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Pharma Track and Trace Solutions Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Pharma Track and Trace Solutions Market Trends
  • Table 2. Pharma Track and Trace Solutions Market Drivers & Opportunity
  • Table 3. Pharma Track and Trace Solutions Market Challenges
  • Table 4. Pharma Track and Trace Solutions Market Restraints
  • Table 5. Global Pharma Track and Trace Solutions Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Pharma Track and Trace Solutions Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Pharma Track and Trace Solutions Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Pharma Track and Trace Solutions Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Pharma Track and Trace Solutions
  • Table 10. Global Pharma Track and Trace Solutions Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma Track and Trace Solutions as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Pharma Track and Trace Solutions Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Pharma Track and Trace Solutions Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Pharma Track and Trace Solutions Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Pharma Track and Trace Solutions Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Pharma Track and Trace Solutions Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Pharma Track and Trace Solutions Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Pharma Track and Trace Solutions Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Pharma Track and Trace Solutions Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Pharma Track and Trace Solutions Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Pharma Track and Trace Solutions Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Pharma Track and Trace Solutions Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Pharma Track and Trace Solutions Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Pharma Track and Trace Solutions Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Pharma Track and Trace Solutions Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Pharma Track and Trace Solutions Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Pharma Track and Trace Solutions Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Pharma Track and Trace Solutions Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Pharma Track and Trace Solutions Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Optel Vision Basic Information List
  • Table 32. Optel Vision Description and Business Overview
  • Table 33. Optel Vision Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of Optel Vision (2020-2025)
  • Table 35. Optel Vision Recent Developments
  • Table 36. Siemens Basic Information List
  • Table 37. Siemens Description and Business Overview
  • Table 38. Siemens Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of Siemens (2020-2025)
  • Table 40. Siemens Recent Developments
  • Table 41. IBM Basic Information List
  • Table 42. IBM Description and Business Overview
  • Table 43. IBM Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of IBM (2020-2025)
  • Table 45. IBM Recent Developments
  • Table 46. Axway Basic Information List
  • Table 47. Axway Description and Business Overview
  • Table 48. Axway Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of Axway (2020-2025)
  • Table 50. Axway Recent Developments
  • Table 51. Mettler-Toledo Basic Information List
  • Table 52. Mettler-Toledo Description and Business Overview
  • Table 53. Mettler-Toledo Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of Mettler-Toledo (2020-2025)
  • Table 55. Mettler-Toledo Recent Developments
  • Table 56. Systech Basic Information List
  • Table 57. Systech Description and Business Overview
  • Table 58. Systech Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of Systech (2020-2025)
  • Table 60. Systech Recent Developments
  • Table 61. SAP Basic Information List
  • Table 62. SAP Description and Business Overview
  • Table 63. SAP Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of SAP (2020-2025)
  • Table 65. SAP Recent Developments
  • Table 66. Seidenader Maschinenbau Basic Information List
  • Table 67. Seidenader Maschinenbau Description and Business Overview
  • Table 68. Seidenader Maschinenbau Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of Seidenader Maschinenbau (2020-2025)
  • Table 70. Seidenader Maschinenbau Recent Developments
  • Table 71. Antares Vision Basic Information List
  • Table 72. Antares Vision Description and Business Overview
  • Table 73. Antares Vision Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of Antares Vision (2020-2025)
  • Table 75. Antares Vision Recent Developments
  • Table 76. Sea Vision Basic Information List
  • Table 77. Sea Vision Description and Business Overview
  • Table 78. Sea Vision Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of Sea Vision (2020-2025)
  • Table 80. Sea Vision Recent Developments
  • Table 81. TraceLink Basic Information List
  • Table 82. TraceLink Description and Business Overview
  • Table 83. TraceLink Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of TraceLink (2020-2025)
  • Table 85. TraceLink Recent Developments
  • Table 86. Adents International Basic Information List
  • Table 87. Adents International Description and Business Overview
  • Table 88. Adents International Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of Adents International (2020-2025)
  • Table 90. Adents International Recent Developments
  • Table 91. Xyntek Basic Information List
  • Table 92. Xyntek Description and Business Overview
  • Table 93. Xyntek Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of Xyntek (2020-2025)
  • Table 95. Xyntek Recent Developments
  • Table 96. Holoflex Basic Information List
  • Table 97. Holoflex Description and Business Overview
  • Table 98. Holoflex Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 99. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of Holoflex (2020-2025)
  • Table 100. Holoflex Recent Developments
  • Table 101. ACG Worldwide Basic Information List
  • Table 102. ACG Worldwide Description and Business Overview
  • Table 103. ACG Worldwide Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 104. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of ACG Worldwide (2020-2025)
  • Table 105. ACG Worldwide Recent Developments
  • Table 106. Key Raw Materials Lists
  • Table 107. Raw Materials Key Suppliers Lists
  • Table 108. Pharma Track and Trace Solutions Downstream Customers
  • Table 109. Pharma Track and Trace Solutions Distributors List
  • Table 110. Research Programs/Design for This Report
  • Table 111. Key Data Information from Secondary Sources
  • Table 112. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Pharma Track and Trace Solutions Product Picture
  • Figure 2. Global Pharma Track and Trace Solutions Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Pharma Track and Trace Solutions Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Pharma Track and Trace Solutions Report Years Considered
  • Figure 5. Global Pharma Track and Trace Solutions Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Pharma Track and Trace Solutions Revenue in 2024
  • Figure 7. Pharma Track and Trace Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Barcodes Picture
  • Figure 9. RFID Picture
  • Figure 10. Global Pharma Track and Trace Solutions Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 11. Global Pharma Track and Trace Solutions Sales Value Market Share by Type, 2024 & 2031
  • Figure 12. Product Picture of Bio Pharma
  • Figure 13. Product Picture of Chemical Pharma
  • Figure 14. Product Picture of Specially Pharma
  • Figure 15. Global Pharma Track and Trace Solutions Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 16. Global Pharma Track and Trace Solutions Sales Value Market Share by Application, 2024 & 2031
  • Figure 17. North America Pharma Track and Trace Solutions Sales Value (2020-2031) & (US$ Million)
  • Figure 18. North America Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031
  • Figure 19. Europe Pharma Track and Trace Solutions Sales Value, (2020-2031) & (US$ Million)
  • Figure 20. Europe Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031
  • Figure 21. Asia Pacific Pharma Track and Trace Solutions Sales Value, (2020-2031) & (US$ Million)
  • Figure 22. Asia Pacific Pharma Track and Trace Solutions Sales Value by Region (%), 2024 VS 2031
  • Figure 23. South America Pharma Track and Trace Solutions Sales Value, (2020-2031) & (US$ Million)
  • Figure 24. South America Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031
  • Figure 25. Middle East & Africa Pharma Track and Trace Solutions Sales Value, (2020-2031) & (US$ Million)
  • Figure 26. Middle East & Africa Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Key Countries/Regions Pharma Track and Trace Solutions Sales Value (%), (2020-2031)
  • Figure 28. United States Pharma Track and Trace Solutions Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. United States Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
  • Figure 30. United States Pharma Track and Trace Solutions Sales Value by Application (%), 2024 VS 2031
  • Figure 31. Europe Pharma Track and Trace Solutions Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Europe Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
  • Figure 33. Europe Pharma Track and Trace Solutions Sales Value by Application (%), 2024 VS 2031
  • Figure 34. China Pharma Track and Trace Solutions Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. China Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
  • Figure 36. China Pharma Track and Trace Solutions Sales Value by Application (%), 2024 VS 2031
  • Figure 37. Japan Pharma Track and Trace Solutions Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. Japan Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
  • Figure 39. Japan Pharma Track and Trace Solutions Sales Value by Application (%), 2024 VS 2031
  • Figure 40. South Korea Pharma Track and Trace Solutions Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. South Korea Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
  • Figure 42. South Korea Pharma Track and Trace Solutions Sales Value by Application (%), 2024 VS 2031
  • Figure 43. Southeast Asia Pharma Track and Trace Solutions Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. Southeast Asia Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
  • Figure 45. Southeast Asia Pharma Track and Trace Solutions Sales Value by Application (%), 2024 VS 2031
  • Figure 46. India Pharma Track and Trace Solutions Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. India Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
  • Figure 48. India Pharma Track and Trace Solutions Sales Value by Application (%), 2024 VS 2031
  • Figure 49. Pharma Track and Trace Solutions Industrial Chain
  • Figure 50. Pharma Track and Trace Solutions Manufacturing Cost Structure
  • Figure 51. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 52. Bottom-up and Top-down Approaches for This Report
  • Figure 53. Data Triangulation
  • Figure 54. Key Executives Interviewed